Harmony Biosciences To Participate In Two Investor Conferences In November
PLYMOUTH MEETING, Pa., Nov. 11, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that Harmony's President and CEO, John C. Jacobs, will participate in fireside chats and host investor meetings at the following upcoming virtual conferences:
The audio webcast of the fireside chats will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/. About Harmony Biosciences Harmony Biosciences Investor Contact: Harmony Biosciences Media Contact:
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-two-investor-conferences-in-november-301421739.html SOURCE Harmony Biosciences |
||
Company Codes: NASDAQ-NMS:HRMY |